Harrow, Inc. (HROW)
45.73
-1.33
(-2.83%)
USD |
NASDAQ |
Dec 15, 16:00
45.70
-0.03
(-0.07%)
After-Hours: 20:00
Harrow Research and Development Expense (Annual): 12.95M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Assertio Holdings, Inc. | 3.822M |
| Skye Bioscience, Inc. | 18.70M |
| Theravance Biopharma, Inc. | 36.04M |
| FibroGen, Inc. | 95.69M |
| NovaBay Pharmaceuticals, Inc. | 0.042M |